• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Current status of platinum-based antitumor drugs.

作者信息

Wong E, Giandomenico C M

机构信息

AnorMed Incorporated, 200-20353 64(th) Avenue, Langley, British Columbia, Canada V2Y 1N5.

出版信息

Chem Rev. 1999 Sep 8;99(9):2451-66. doi: 10.1021/cr980420v.

DOI:10.1021/cr980420v
PMID:11749486
Abstract
摘要

相似文献

1
Current status of platinum-based antitumor drugs.铂类抗肿瘤药物的现状
Chem Rev. 1999 Sep 8;99(9):2451-66. doi: 10.1021/cr980420v.
2
[Current status of and future perspectives for platinum antitumor drugs].[铂类抗肿瘤药物的现状与未来展望]
Yakugaku Zasshi. 2008 Mar;128(3):307-16. doi: 10.1248/yakushi.128.307.
3
Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.非经典铂类抗肿瘤药物:顺铂互补新药的设计与开发前景
Cancer Invest. 1993;11(5):578-89. doi: 10.3109/07357909309011676.
4
Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.一系列反式铂抗肿瘤配合物的合成及其体内外抗肿瘤活性
J Med Chem. 1995 Aug 4;38(16):3016-24. doi: 10.1021/jm00016a004.
5
Development and current status of unconventional platinum anticancer complexes.非常规铂类抗癌配合物的发展与现状
Mini Rev Med Chem. 2007 Feb;7(2):203-11. doi: 10.2174/138955707779802615.
6
Liposomes, a promising strategy for clinical application of platinum derivatives.脂质体,铂类衍生物临床应用的一种有前途的策略。
Expert Opin Drug Deliv. 2013 Jun;10(6):829-44. doi: 10.1517/17425247.2013.778240. Epub 2013 Mar 8.
7
[Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].[体内抗肿瘤活性唑桥联双核铂(II)配合物的药物发现研究]
Yakugaku Zasshi. 2012;132(3):253-9. doi: 10.1248/yakushi.132.253.
8
Unique platinum-DNA interactions may lead to more effective platinum-based antitumor drugs.独特的铂-DNA 相互作用可能导致更有效的铂类抗肿瘤药物。
Metallomics. 2011 Jul;3(7):650-5. doi: 10.1039/c1mt00012h. Epub 2011 Apr 26.
9
Inorganic Nano-Targeted Drugs Delivery System and Its Application of Platinum-Based Anticancer Drugs.无机纳米靶向给药系统及其在铂类抗癌药物中的应用
J Nanosci Nanotechnol. 2017 Jan;17(1):1-17. doi: 10.1166/jnn.2017.12932.
10
The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy.利用聚合铂(IV)前药递送具有降低的全身毒性和增强的抗肿瘤功效的多核铂(II)药物。
Biomaterials. 2012 Nov;33(33):8657-69. doi: 10.1016/j.biomaterials.2012.08.015. Epub 2012 Aug 28.

引用本文的文献

1
Evaluating Naphthalene-Modified Metallosalen Complexes as Anticancer Agents.评估萘修饰的金属卟啉配合物作为抗癌剂的性能。
J Med Chem. 2025 Jul 24;68(14):14300-14311. doi: 10.1021/acs.jmedchem.4c03180. Epub 2025 Jul 15.
2
Protonation of Pt(IV) Anticancer Complexes Assayed by Vibrational Ion Spectroscopy.通过振动离子光谱法测定的铂(IV)抗癌配合物的质子化作用
Chempluschem. 2025 Jun;90(6):e202400754. doi: 10.1002/cplu.202400754. Epub 2025 Apr 3.
3
Targeted inhibition of BET proteins in HPV16-positive head and neck squamous cell carcinoma reveals heterogeneous transcriptional responses.
对人乳头瘤病毒16型阳性头颈部鳞状细胞癌中BET蛋白的靶向抑制揭示了异质性转录反应。
Front Oncol. 2024 Sep 5;14:1440836. doi: 10.3389/fonc.2024.1440836. eCollection 2024.
4
New imidazolidindionedioximes and their Pt(II) complexes: synthesis and investigation of their antitumoral activities on breast cancer cells.新型咪唑烷二酮二肟及其铂(II)配合物:其对乳腺癌细胞的抗肿瘤活性的合成与研究
Turk J Chem. 2024 Jan 22;48(4):582-596. doi: 10.55730/1300-0527.3681. eCollection 2024.
5
A Comprehensive Review on the Development of Titanium Complexes as Cytotoxic Agents.钛配合物作为细胞毒剂的发展综述。
Curr Top Med Chem. 2024;24(24):2117-2128. doi: 10.2174/0115680266317770240718080512.
6
Ruthenium(II) complexes of curcumin and β-diketone derivatives: effect of structural modifications on their cytotoxicity.姜黄素与β-二酮衍生物的钌(II)配合物:结构修饰对其细胞毒性的影响。
R Soc Open Sci. 2024 Jul 31;11(7):240353. doi: 10.1098/rsos.240353. eCollection 2024 Jul.
7
Interactions with DNA Models of the Oxaliplatin Analog (-1,3-DACH)PtCl.与奥沙利铂类似物(-1,3-DACH)PtCl 的 DNA 模型的相互作用。
Int J Mol Sci. 2024 Jul 5;25(13):7392. doi: 10.3390/ijms25137392.
8
and its Combination with Cisplatin: A Potential Anticancer Candidate by Modulating Apoptotic Genes.并与顺铂联合应用:通过调节凋亡基因成为一种有潜力的抗癌候选药物。
Anticancer Agents Med Chem. 2024;24(16):1233-1240. doi: 10.2174/0118715206296649240625072637.
9
Binding energies and hydrogen bonds effects on DNA-cisplatin interactions: a DFT-xTB study.结合能和氢键效应对 DNA-顺铂相互作用的影响:DFT-xTB 研究。
J Mol Model. 2024 May 27;30(6):187. doi: 10.1007/s00894-024-05983-4.
10
A Comparison of Studies between Cobalt(III) and Copper(II) Complexes with Thiosemicarbazone Ligands to Treat Triple Negative Breast Cancer.钴(III)和铜(II)与硫代氨基脲配体形成的配合物治疗三阴性乳腺癌的研究比较
Inorganica Chim Acta. 2024 Mar 1;562. doi: 10.1016/j.ica.2023.121898. Epub 2023 Dec 22.